Raptor Pharmaceuticals Corp. (OTC BB: RPTP)

Raptor Pharmaceuticals Corp. (OTC BB: RPTP) has its business strategically divided into two segments: its 100% ownership of Raptor Pharmaceutical Inc., a development stage biotechnology company focused on bioengineeing drug candidates and drug-targeting platforms derived from the human receptor-associated protein and related proteins; and its 100% ownership of Bennu Pharmaceuticals Inc., a development stage company created with the purpose of developing clinical-stage products. For further information, visit the Company’s web site at www.raptorpharma.com.